Evidence map›Paper›PMID 22615941›Full record

ArticlePloS one2012

Immunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance.

Toshiaki Nakano, Chia-Yun Lai, Shigeru Goto, Li-Wen Hsu, Seiji Kawamoto, Kazuhisa Ono, Kuang-Den Chen, Chih-Che Lin, King-Wah Chiu, Chih-Chi Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Translational medical research and liver transplantation: systematic review.Translational gastroenterology and hepatology · 2018
    Review
  13. The emerging role of mast cells in liver disease.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Review
  14. Isolation and characterization of hepatic mast cells from cholestatic rats.Laboratory investigation; a journal of technical methods and pathology · 2016
    Article
  15. Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Toshiaki NakanoGraduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Niao-Sung, Taiwan. toshi.nakano@msa.hinet.net
Chia-Yun Lai
Shigeru Goto
Li-Wen Hsu
Seiji Kawamoto
Kazuhisa Ono
Kuang-Den Chen
Chih-Che Lin
King-Wah Chiu
Chih-Chi Wang
Yu-Fan Cheng
Chao-Long Chen
Kaohsiung Chang Gung Memorial Hospital · TWMemorial Hospital of South Bend · USChang Gung University · TWHiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise roles of mast cells in liver allograft rejection and tolerance are still unknown. This study aimed to explore the roles of mast cells in immune regulation and liver regeneration for tolerance induction by using rat models of orthotopic liver transplantation (OLT). Stem cell factor (SCF) and its receptor c-Kit, which are critical to the migration and development of not only stem cells but also mast cells, significantly increased in the tolerogenic livers as compared with rejected livers. The significant elevation of mast cell tryptase, high-affinity IgE receptor, and histamine suggested the activation of mast cells in liver allografts at the tolerogenic phase after OLT. Immunohistochemical analysis using confocal microscope clearly showed colocalization of mast cells, Foxp3+ Tregs, γδ T cells, and recipient-derived hepatic progenitor cells with higher expression of SCF, IL-9, IL-10, TGF-β1, and IL-17 related to immunoregulation and liver regeneration in the donor grafts of a tolerogenic OLT model. Cross-talk among mast cells and other cells was evaluated by in vitro studies demonstrating that syngeneic bone marrow-derived mast cells (BMMCs) co-cultured with naïve splenocytes or primary hepatocytes significantly increased the population of splenic γδ T cells by mitogen stimulation or by mast cell degranulation, and also significantly induced the hepatocyte proliferation, respectively. Our results suggested that mast cells in the donor grafts may play important roles in the induction/maintenance of immune tolerance and liver regeneration resulting in the replacement of hepatic cells from donor to recipient.

Indexed as

AnimalsForkhead Transcription FactorsGraft RejectionHepatocytesImmune ToleranceInterleukin-10Interleukin-17Liver RegenerationLiver TransplantationMast CellsProto-Oncogene Proteins c-kitRatsSpleenStem Cell FactorT-Lymphocytes, RegulatoryTransforming Growth Factor beta1Forkhead Transcription FactorsFoxp3 protein, ratInterleukin-10Interleukin-17Proto-Oncogene Proteins c-kitStem Cell FactorTransforming Growth Factor beta1

Identifiers

PMID22615941
PMCPMC3352886
OpenAlexW1970567448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.